Glucose Metabolism After Kidney Transplantation: Insulin Release and Sensitivity With Tacrolimus- Versus Belatacept-Based Immunosuppression

Am J Kidney Dis. 2021 Mar;77(3):462-464. doi: 10.1053/j.ajkd.2020.07.016. Epub 2020 Sep 6.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abatacept / therapeutic use*
  • Adult
  • Aged
  • Diabetes Mellitus / epidemiology
  • Diabetes Mellitus / metabolism*
  • Female
  • Glucose Tolerance Test
  • Graft Rejection / prevention & control
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Insulin Resistance*
  • Insulin Secretion*
  • Kidney Transplantation*
  • Male
  • Middle Aged
  • Postoperative Complications / epidemiology
  • Postoperative Complications / metabolism*
  • Tacrolimus / therapeutic use*

Substances

  • Immunosuppressive Agents
  • Abatacept
  • Tacrolimus